Quantitation of minimal residual disease in multiple myeloma using an allele-specific real-time PCR assay

Experimental Hematology

Volumn 28, Issue 9, 2000, Pages 1039-1045

  Rasmussen, Thomas ^a   Poulsen, Tim Svenstrup ^a   Honoré, Lone ^a   Johnsen, Hans Erik ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

IgH gene rearrangements; Minimal residual disease; Multiple myeloma; Real time quantitative PCR

Indexed keywords

DEXAMETHASONE; DOXORUBICIN; IMMUNOGLOBULIN HEAVY CHAIN; NUCLEASE; VINCRISTINE;

ADULT; ALLELE; ANALYTIC METHOD; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; MINIMAL RESIDUAL DISEASE; MULTIPLE MYELOMA; PLASMA CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REPRODUCIBILITY; SEQUENCE ANALYSIS;

ADULT; ALLELES; BONE MARROW; CLONE CELLS; COMPARATIVE STUDY; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMAN; IMMUNOGLOBULINS; MIDDLE AGE; MULTIPLE MYELOMA; NEOPLASM PROTEINS; NEOPLASM, RESIDUAL; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUPPORT, NON-U.S. GOV'T;

EID: 0033801695     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(00)00514-2     Document Type: Article

References (24)

1. Deane M., Norton J.D. Immunoglobulin gene 'fingerprinting'. an approach to analysis of B lymphoid clonality in lymphoproliferative disorders Br J Haematol. 77:1991;274.
2. Corradini P, Voena C, Omede P, et al. (1993) Detection of circulating tumor cells in multiple myeloma by a PCR-based method. Leukemia 7:1879.
3. Owen R.G., Johnson R.J., Evans P.A., Smith G.M., Child J.A., Morgan G.J. Detection of clonal immunoglobulin gene rearrangements in the PBPC harvests of patients with acute lymphoblastic leukaemia. Bone Marrow Trans. 16:1995;831.
4. Cao J., Vescio R.A., Hong C.H., Kim A., Lichtenstein A.K., Berenson J.R. Identification of malignant cells in multiple myeloma bone marrow with immunoglobulin VH gene probes by fluorescent in situ hybridization and flow cytometry. J of Clin Invest. 95:1995;964.
5. Billadeau D., Prosper F., Verfaillie C., Weisdorf D., Van N.B. Sequential analysis of bone marrow and peripheral blood after stem cell transplant for myeloma shows disparate tumor involvement. Leukemia. 11:1997;1565.
6. Cooke F., Bakkus M., Thielemans K., Pico J.L., Apperley J.F., Samson D. Use of quantitative ASO-PCR to predict relapse in multiple myeloma. Br J Haematol. 105:1999;317.
7. Billadeau D., Quam L., Thomas W.et al. Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients. Blood. 80:1992;1818.
8. Vescio R.A., Han E.J., Schiller G.J.et al. Quantitative comparison of multiple myeloma tumor contamination in bone marrow harvest and leukapheresis autografts. Bone Marrow Trans. 18:1996;103.
9. Gazitt Y., Tian E., Barlogie B.et al. Differential mobilization of myeloma cells and normal hematopoietic stem cells in multiple myeloma after treatment with cyclophosphamide and granulocyte-macrophage colony-stimulating factor. Blood. 87:1996;805.
10. Rasmussen T., Honore L., Johnsen H.E. Identification and characterization of malignant cells using RT-PCR on single flowsorted cells. Med Oncol. 15:1998;96.
11. Bergsagel P.L., Smith A.M., Szczepek A., Mant M.J., Belch A.R., Pilarski L.M. In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain. Blood. 85:1995;436.
12. Elsworth A.M., Evans P.A., Morgan G.J., Kinsey S.E., Shiach C.R. Quantitative PCR of the immunoglobulin heavy chain gene using genomic DNA. Br J Haematol. 95:1996;700.
13. Gibson U.E., Heid C.A., Williams P.M. A novel method for real time quantitative RT-PCR. Genome Res. 6:1996;995.
14. Heid C.A., Stevens J., Livak K.J., Williams P.M. Real time quantitative PCR. Genome Res. 6:1996;986.
15. Dolken L., Schuler F., Dolken G. Quantitative detection of t(14;18)-positive cells by real-time quantitative PCR using fluorogenic probes. Biotechniques. 25:1998;1058.
16. Marcucci G., Livak K.J., Bi W., Strout M.P., Bloomfield C.D., Caligiuri M.A. Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay. Leukemia. 12:1998;1482.
17. Mensink E., van de Locht A., Schattenberg A.et al. Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR. Br J Haematol. 102:1998;768.
18. Pongers-Willemse M.J., Verhagen O.J., Tibbe G.J.et al. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes. Leukemia. 12:1998;2006.
19. Gerard C.J., Olsson K., Ramanathan R., Reading C., Hanania E.G. Improved quantitation of minimal residual disease in multiple myeloma using real-time polymerase chain reaction and plasmid-DNA complementarity determining region III standards. Cancer Res. 58:1998;3957.
20. Sanz I. Multiple mechanisms participate in the generation of diversity of human H chain CDR3 regions. J Immunol. 147:1991;1720.
21. Bakkus M.H., Van R.I., Van C.B., Thielemans K. Evidence that the clonogenic cell in multiple myeloma originates from a pre-switched but somatically mutated B cell. British Journal of Haematology. 87:1994;68.
22. Cook G.P., Tomlinson I.M. The human immunoglobulin VH repertoire. Immunol Today. 16:1995;237.
23. Billadeau D., Blackstadt M., Greipp P.et al. Analysis of B-lymphoid malignancies using allele-specific polymerase chain reaction. a technique for sequential quantitation of residual disease Blood. 78:1991;3021.
24. Ladetto M., Donovan J.W., Schlossman R.L., Anderson K.C., Gribben J.G. Limitations of quantitative detection of immunoglobulin heavy chain (IgH) gene rearrangement in multiple myeloma (MM) patients using real-time PCR. Blood. 92(Suppl 1):1998;258a.